A00661-1
antibody from Boster Biological Technology
Targeting: KLRK1
CD314, D12S2489E, KLR, NKG2-D, NKG2D
Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- A00661-1 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-NKG2D/KLRK1 Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for NKG2D/KLRK1 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Mouse. NKG2D/KLRK1 information: Subcellular Localization: Cell membrane; Tissue Specificity: Expressed in natural killer (NK) cells, CD8(+) alpha-beta and gamma-delta T-cells. Expressed on essentially all CD56+CD3- NK cells from freshly isolated PBMC. Expressed in interferon-producing killer dendritic cells (IKDCs).
- Reactivity
- Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- 0.5-1mg/ml, actual concentration vary by lot. Use suggested dilution ratio to decide dilution procedure.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Interleukin-15 gene therapy and the mammalian target of rapamycin inhibitor everolimus inhibit the growth of metastatic breast cancer.
Zhao N, Li X, He X, Qiu Y, Zhu L, Qi F
The journal of gene medicine 2013 Oct;15(10):366-74
The journal of gene medicine 2013 Oct;15(10):366-74
No comments: Submit comment
No validations: Submit validation data